Attached files

file filename
10-K - 10-K - Travere Therapeutics, Inc.rtrx-20191231x10k.htm
EX-32.2 - EXHIBIT 32.2 - Travere Therapeutics, Inc.ex322-1231201910k.htm
EX-32.1 - EXHIBIT 32.1 - Travere Therapeutics, Inc.ex321-1231201910k.htm
EX-31.2 - EXHIBIT 31.2 - Travere Therapeutics, Inc.ex312-1231201910k.htm
EX-31.1 - EXHIBIT 31.1 - Travere Therapeutics, Inc.ex311-1231201910k.htm
EX-23.1 - EXHIBIT 23.1 - Travere Therapeutics, Inc.ex231-1231201910k.htm
EX-10.37 - EXHIBIT 10.37 - Travere Therapeutics, Inc.ex1037-1231201910k.htm
EX-5.1 - EXHIBIT 5.1 - Travere Therapeutics, Inc.ex511231201910k.htm
EX-4.2 - EXHIBIT 4.2 - Travere Therapeutics, Inc.ex42-1231201910k.htm
EX-1.1 - EXHIBIT 1.1 - Travere Therapeutics, Inc.ex11-1231201910k.htm


EX
Exhibit 21.1
RETROPHIN, INC.
LIST OF SUBSIDIARIES
No. 
 
Name
1
 
Retrophin Pharmaceutical, Inc.
2
 
Retrophin Therapeutics I, Inc.
3
 
Retrophin Therapeutics II, Inc.
4
 
Retrophin Europe Ltd
5
 
Retrophin International Holdings Ltd
6
 
RTRX International CV
7
 
Retrophin Therapeutics International LLC
8
 
US LLC 2
9
 
Retrophin Research Ltd
10
 
Retrophin US Holdings LLC
11
 
Manchester Pharmaceuticals LLC
12
 
Centurion Merger Sub, Inc.
13
 
[10-em856580]